The effect of spinal cord injury on the expression of TGF-β and TNF-α in rat articular cartilage

Objective: To observe the expression of TGF-β and TNF-α in the spinal cord injured rat model and discuss the significance of the articular cartilage metabolism. Methods: 36 SD female rats were randomly divided into 2 groups: Rats models of spinal cord injury were implemented by Allen method. T10 laminectomy was performed in the control group. Both groups of rats were killed respectively in 1w, 3w and 6w. Hematoxylin-eosin stain was given to each slice in the model group and control group. Immunohistochemical stain was applied by using ABC method in the expression of TGF-β and TNF-α. Those expressed level were performed in image analysis and statistics process. Results: TGF-β and TNF-α were mainly distributed on the surface layer of the articular cartilage, with a weak expression in control group. The expression of TNF-α in the model group was more significant than that in the control group in the 1w, and still remained an evident difference with that in control group until the 6w(P ＜ 0.05). TGF-β expression of the model group had no remarkable difference with the control group in the lw (P ＞ 0.05) and prominently became stronger at 6w(P ＜ 0.05). Conclusion: The expression of TNF-o occurred early in the development of spinal cord injury, and the expression of TGF-β became stronger with the revival of spinal neural function. Both expressions were strengthened in articular cartilage in the 3rd week.     

The effect of spinal cord injury on the expression of TGF-β and TNF-α in rat articular cartilage

Objective： To observe the expression of TGF-β and TNF-α in the spinal cord injured rat model and discuss the significance of the articular cartilage metabolism. Methods： 36 SD female rats were randomly divided into 2 groups： Rats models of spinal cord injury were implemented by Allen method. T10 laminectomy was performed in the control group. Both groups of rats were killed respectively in 1w, 3w and 6w. Hematoxylin-eosin stain was given to each slice in the model group and control group. Immunohistochemical stain was applied by using ABC method in the expression of TGF-β and TNF-α. Those expressed level were performed in image analysis and statistics process. Results： TGF-β and TNF-α were mainly distributed on the surface layer of the articular cartilage, with a weak expression in control group. The expression of TNF-α in the model group was more significant than that in the control group in the lw, and still remained an evident difference with that in control group until the 6w（P 〈 0.05）. TGF-β expression of the model group had no remarkable difference with the control group in the lw （P 〉 0.05） and prominently became stronger at 6w（P 〈 0.05）. Conclusion： The expression of TNF-α occurred early in the development of spinal cord injury, and the expression of TGF-β became stronger with the revival of spinal neural function. Both expressions were strengthened in articular cartilage in the 3rd week.     

Effects of Yixin Jiangya Capsules on Insulin Resistance and Tumor Necrosis Factor-α in Cases of Primary Hypertension with Left Ventricular Hypertrophy

Objectives: To observe the effects of Yixin Jiangya Capsules (益心降压胶囊 capsules for nourishing the heart and lowering blood pressure) on insulin resistance (IR) and tumor necrosis factor-α (TNF-α) in patients with primary hypertension with left ventricular hypertrophy (LVH). Methods: Totally 93 cases were randomly divided into a control group of 31 cases taking Enalapril and a treatment group of 62 cases taking Enalapril and Yixin Jiangya Capsules. Results: Fasting serum insulin (FSI) and TNF-α obviously increased and insulin sensitive index (ISI) significantly decreased in both groups before treatment as compared to those of a healthy group. After treatment, FSI, TNF-α and fasting blood glucose (FBG) obviously decreased and ISI remarkably increased in the treatment group, while ISI significantly increased and TNF-α obviously decreased in the control group. The curative effect in the treatment group was remarkably superior to that in the control group. FSI was positively related to TNF-α before treatment in both groups. Conclusion: FSI and TNF-α obviously increase and ISI significantly decreases in patients with primary hypertension with LVH. FSI and TNF-α influencing each other are involved in the generation and development of hypertension. Yixin Jiangya Capsules can improve IR and decrease TNF-α.     

The relationship between PGE2 level in mothers'' milk and physiological diarrhea of the baby and the treatment.

Physiological diarrhea of baby during the period of breastfeeding often occures. To investigate the relationship between mother's milk and the physiological diarrhea of baby, we measured the PGE_2 levels in milk of 320 lactating women within 4 months of postpartum with radioimmunoassay and the mean value of PGE_2 level was 216.8 145.2 ng/L. The PGE_2 levels in mother's milk in the group with diarrhea were 286.5±142.2 ng/L, that of control group 130.4±76.3 ng/L. The difference was obviously significant (P<0.001). The physiological diarrhea of baby was positively related to the PGE_2 level in mother's milk (r=0.75, P<0.01) i.e., the high PGE_2 level in mother's milk may be an important cause of diseases. The ob servation on 102 cases of baby with severe physiological diarrhea showed a higher level of PGE_2 in the mother's milk. 52 cases of lactating women in the treated group were given indomethacin, and after treatment the PGE_2 level in mother's milk decreased obviously, and the diarrhea of baby diaspp     

Clinical Observation on Influence of Chinese Medicines for Promoting Blood Circulation to Remove Blood Stasis on FIB and DD in Plasma of Patients with Cerebral Thrombosis

to study the influence of Chinese medicines for promoting blood circulation to removeblood stasis on fibrinogen(FIB)and D-dimer(DD)in plasma of patients with cerebral thrombosis.Method:73 inpatients with acute cerebral thrombosis were randomly divided into a control group of34 cases and a treatment group of 39 cases.The content of FIB and DD in plasma was detectedbefore treatment and on the 7th and 14th days after treatment.Result:FIB content in plasma aftertreatment was lower than that before treatment in the control group(P<0.01)and more remarkablein the treatment group(P<0.001).There was an obvious difference in DD content before and aftertreatment in both groups.DD content on the 7th and 14th days after treatment in the treatmentgroup was obviously higher than that in the control group(P<0.01 and P<0.05 respectively).Conclusion:Chinese medicines for promoting blood circulation to remove blood stasis can reducethe FIB content in plasma of patients with cerebral thrombosis,raise the DD content in plasma,cause the peak of DD content appear earlier and obviously improve hypercoagulability of blood inpatients with cerebral thrombosis.     

Effect of Liangxue Huoxue Xiaoyin Tang on Serum Levels of TNF-α, IFN-γ and IL-6 in Psoriasis of Blood-Heat Type

To explore the effect of Liangxue Huoxue Xiaoyin Tang （LHXT 凉血活血消银汤 Decoction of Removing Heat from the Blood and Promoting Blood Flow to Eliminate Psoriasis） on serum levels of tumor necrosis factor-or （TNF-α）, interferon （IFN-γ） and interleukin-6 （IL-6） in psoriasis of blood-heat type. Blood samples from both the treatment group （N=33） and control group （N=30） were taken before and after treatment, and the serum levels of TNF-ct, IFN-T and IL-6 were determined by radio-immunoassay and ELISA. The total effective rate achieved in the treatment group was 90.91%. The remarkably high serum levels of TNF-α IFN-γ and IL-6 in patients before treatment （P〈0.01） were obviously decreased after one course of treatment （P〈0.05） and were close to those of healthy subjects after two course of treatment （P〉0.05）. The data demonstrate that LHXT has the actions of reducing serum levels of TNF-α, IFN-γ and IL-6 in psoriasis of blood-heat type, and may exert a pharmacological effect targeting at the cytokines.     

Clinical Effects of Lianbai Liquid in Prevention and Treatment of Dermal Injury Caused by Radiotherapy

Objective: To observe the effect of Lianbai liquid (连柏液) in prevention and treatment of acute radiation dermal injury. Method: From May 2000 to December 2005, 126 cancer patients were randomly divided into a prevention group of 75 cases given externally topical application of Lianbai liquid since the first radiotherapy, and a control group Ⅰ of 51 cases given only advice after radiotherapy; while the other 92 cancer patients who had already had grade Ⅲ acute radiation-induced dermal injury were randomly divided into a treatment group of 54 cases treated by externally topical use of Lianbai liquid, and a control group Ⅱ of 38 cases treated by topical use of norfloxacin. Clinical evaluation was carried out according to the CTC.V2.0 standard stipulated by NCI for classifying acute radiation dermal injury. Results: The incidence of skin reaction was 32.0% in the prevention group and 92.2% in the control group Ⅰ, with an obvious difference between the two groups (χ2=54.163, P<0.01). Mild radioactive reaction (grade Ⅰ and Ⅱ) was 28.0% (21/75) in the prevention group and 70.6% (36/51) in the control group Ⅰ, with a remarkable difference between the two groups (χ2=22.226, P<0.01). The effective rate for grade Ⅲ dermal injury was 92.6% (50/54) in the treatment group and 65.9% (25/38) in the control group Ⅱ, with a remarkable difference between the two groups (χ2=6.018, P=0.024). The wound-healing time was 11.07±2.21 days in the treatment group and 18.08±1.76 days in the control group Ⅱ, with a remarkable difference between the two groups (u=16.932, P<0.01). Conclusion: Lianbai liquid can effectively prevent the radiation dermatitis, and treat grade Ⅲ acute radiation dermal injury with obvious curative effect.     

Clinical study on effect of Astragalus Injection (黄芪注射液) and its immuno-regulation action in treating chronic aplastic anemia

Objective:To observe the clinical effect of Astragalus Injection(黄芪注射液,AI) and its immuno-regulatory action in treating chronic aplastic anemia(CAA).Methods:Sixty patients with CAA were randomly assigned to two groups equally,both were treated with Stanozolol three times a day,2 mg each time through oral intake,but AI was given additionally to the patients in the treated group once a day via intravenous dripping.All were treated for 15 days as one therapeutic course and the whole medication lasted for more than 4 months totally,with follow-up adopted.The clinical effi cacy was estimated and the changes of T-lymphocyte subsets in peripheral blood as well as the serum levels of tumor necrosis factor-α(TNF-α) and interleukin-2(IL-2) were observed.Results:The total effective rate in the treated group was 83.3%(25/30),which was higher than that in the control group 66.7%(20/30),showing significant difference between them(P<0.05).Levels of hemoglobin,WBC,reticular cell and platelet were elevated in both groups after treatment,but the improvement was signif icantly better in the treated group than that in the control group with respect to the former three indexes(P<0.05).The level of CD4 increased and that of CD8 decreased signifi cantly after treatment in the treated group(P<0.05),which showed significant difference as compared with those in the control group(P<0.05).Levels of serum TNF-α and IL-2 lowered after treatment in both groups,but signifi cance only showed in the treated group(P<0.05).The degree of proliferation in bone marrow got raised signifi cantly and the percentage of non-hemopoietic cells reduced signifi cantly in the treated group after treatment,also showing significant difference to those in the control group(P<0.05).Conclusion:AI could promote the recovery of hemopoietic function,which might be through improving T-lymphocyte subsets and reducing the release of negative regulatory factors such as TNF-α and IL-2 to alleviate the inhibition on hemopoietic function.     

Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide induced peritonitis

Background The nervous system, through the vagus nerve and its neurotransmitter acetylcholine, can down-regulate the systemic inflammation in vivo, and recently, a role of brain cholinergic mechanisms in activating this cholinergic anti-inflammatory pathway has been indicated. Galanthamine is a cholinesterase inhibitor and one of the centrally acting cholinergic agents available in clinic. This study aimed to evaluate the effect of galanthamine on circulating tumor necrosis factor alpha (TNF-α) in rats with lipopolysaccharide-induced peritonitis and the possible role of the vagus nerve in the action of galanthamine.Methods Rat models of lipopolysaccharide-induced peritonitis and bilateral cervical vagotomy were produced. In the experiment 1, the rats were randomly divided into control group, peritonitis group, and peritonitis groups treated with three dosages of galanthamine. In the experiment 2, the rats were randomly divided into sham group, sham plus peritonitis group, sham plus peritonitis group treated with galanthamine, vagotomy plus peritonitis group, and vagotomy plus peritonitis group treated with galanthamine. The levels of plasma TNF-α were determined in every group. Results The level of circulating TNF-α was significantly increased in rats after intraperitoneal injection of endotoxin. Galanthamine treatment decreased the level of circulating TNF-α in rats with lipopolysaccharide-induced peritonitis, and there was significant difference compared with rats with lipopolysaccharide-induced peritonitis without treatment. The 3 mg/kg dosage of galanthamine had the most significant inhibition on circulating TNF-α level at all the three tested doses. Galanthamine obviously decreased the TNF-α level in rats with lipopolysaccharide-induced peritonitis with sham operation, but could not decrease the TNF-α level in rats with lipopolysaccharide-induced peritonitis with vagotomy. Conclusion Cholinesterase inhibitor galanthamine has an inhibitory effect on TNF-α release in rats with lipopolysaccharide-induced peritonitis, and the vagus nerve plays a role in the process of the action of galanthamine.     

Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide- induced peritonitis

Background The nervous system, through the vagus nerve and its neurotransmitter acetylcholine, can down-regulate the systemic inflammation in vivo, and recently, a role of brain cholinergic mechanisms in activating this cholinergic anti-inflammatory pathway has been indicated. Galanthamine is a cholinesterase inhibitor and one of the centrally acting cholinergic agents available in clinic. This study aimed to evaluate the effect of galanthamine on circulating tumor necrosis factor alpha （TNF-a） in rats with lipopolysaccharide-induced peritonitis and the possible role of the vagus nerve in the action of galanthamine. Methods Rat models of lipopolysaccharide-induced peritonitis and bilateral cervical vagotomy were produced. In the experiment 1, the rats were randomly divided into control group, peritonitis group, and peritonitis groups treated with three dosages of galanthamine. In the experiment 2, the rats were randomly divided into sham group, sham plus peritonitis group, sham plus peritonitis group treated with galanthamine, vagotomy plus peritonitis group, and vagotomy plus peritonitis group treated with galanthamine. The levels of plasma TNF-α were determined in every group. Results The level of circulating TNF-α was significantly increased in rats after intraperitoneal injection of endotoxin. Galanthamine treatment decreased the level of circulating TNF-α in rats with lipopolysaccharide-induced peritonitis, and there was significant difference compared with rats with lipopolysaccharide-induced peritonitis without treatment. The 3 mg/kg dosage of galanthamine had the most significant inhibition on circulating TNF-α level at all the three tested doses. Galanthamine obviously decreased the TNF-a level in rats with lipopolysaccharide-induced peritonitis with sham operation, but could not decrease the TNF-α level in rats with lipopolysaccharide-induced peritonitis with vagotomy. Conclusion Cholinesterase inhibitor galanthamine has an inhibitory effect on TNF-α release in rats with Iipopolysaccharide-induced peritonitis, and the vagus nerve plays a role in the process of the action of galanthamine.     

毒结清口服液联合化疗治疗多发性骨髓瘤骨病临床研究

目的:探讨以毒结清口服液治疗多发性骨髓瘤(MM)患者骨病的临床疗效。方法:将42例MM患者随机分成两组,对照组20例予M2方案化疗,中药组22例予中药毒结清口服液60mL/d,同时予M2方案化疗。以血钙和白介素-6(IL-6)水平下降,骨痛的缓解和生活质量改善为评价指标。结果:中药组和对照组治疗后骨痛症状评分均明显下降,与治疗前比较差异均有显著性意义(P<0.05);中药组生活质量总有效率为68.2%,与对照组总有效率(45%)比较差异均有显著性意义(P<0.05);中药组治疗后血钙和IL-6水平均明显下降(P<0.05),与对照组治疗后血钙和IL-6水平比较差异也有显著性意义(P<0.05);对照组治疗后血钙水平较治疗前有下降(P>0.05)。结论:毒结清口服液联合化疗能有效降低MM患者血钙和IL-6水平,改善骨痛症状,提高生活质量。     

罗格列酮对初发2型糖尿病合并肥胖患者炎症状态及胰岛素抵抗的影响

目的 探讨罗格列酮对初发2型糖尿病合并肥胖患者血清高敏C反应蛋白(hs-CRP)、白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)及胰岛素抵抗的影响.方法 118例初发2型糖尿病合并肥胖患者随机分为两组:A组口服罗格列酮(4 mg/d)12周,B组予磺脲类降糖药物治疗12周.检测两组患者治疗前后血清中hs-CRP、IL-1β、IL-6、TNF-水平及空腹血糖(FPG)、空腹血浆胰岛素(FINS)浓度,根据HOMA Model公式计算胰岛素抵抗指数.结果 A组患者治疗后血清hs-CRP、IL-1β、IL-6、TNF-α水平及空腹血糖、胰岛索抵抗指数显著低于治疗前(P<0.01);治疗后A组患者空腹血糖较B组患者无明显差异(P>0.05),但血清hs-CRP、IL-1β、IL-6、TNF-α水平及胰岛素抵抗指数显著低于B组患者(P<0.05).结论 罗格列酮降低2型糖尿病合并肥胖患者血糖同时,降低患者机体炎症状态.改善胰岛素抵抗.     

珍黄液治疗对支气管肺炎患儿可溶性细胞间黏附因子和C反应蛋白的影响

【目的】探讨珍黄液治疗对支气管肺炎患儿可溶性细胞间黏附因子-1(sICAM-1)和C反应蛋白(CRP)的影响。【方法】采用半随机对照方法将60例支气管肺炎患儿分为对照组30例和观察组30例,对照组给予常规综合治疗,观察组在常规综合治疗的基础上加用珍黄液(由牛黄、珍珠层粉组成)口服。观察其临床综合疗效和治疗前后sICAM-1、CRP的水平变化。【结果】(1)观察组的总有效率为96.7%,对照组为53.3%,2组比较差异有统计学意义(P<0.05),表明观察组的临床综合疗效优于对照组。(2)治疗后观察组的sICAM-1及CRP水平均显著下降,与治疗前比较差异有统计学意义(P<0.05),与对照组治疗后比较,差异有统计学意义(P<0.05),表明观察组在改善患儿的sICAM-1及CRP指标方面作用优于对照组。【结论】珍黄液作为治疗小儿支气管肺炎的专方制剂疗效确切,对增强患儿自身免疫功能,减轻炎症反应有一定疗效。     

口服胰岛素抑制胰岛β细胞凋亡预防NOD鼠糖尿病

目的: 观察口服胰岛素免疫干预对非肥胖糖尿病(non-obese diabetic, NOD)鼠胰岛炎、β细胞凋亡和糖尿病的影响,并探讨其诱导免疫耐受的机制.方法: 86只NOD雌鼠随机分为胰岛素处理组(n=43)和磷酸盐缓冲液(phosphate buffered saline, PBS)对照组(n=43),从4周龄始每周灌胃人普通胰岛素1mg(70μL)2次,12周后改为每周灌胃1次至30周,对照组予等体积的PBS;于12周龄观察胰岛炎和胰岛β细胞凋亡;检测胰岛Fas和FasL的表达;测定血清IL-4和IFN-γ浓度,以及胰岛内I-Aβg7,IL-1β,IFN-γ,Fas,IL-4,TGF-β mRNA和小肠PP(Peyer's Patch)淋巴结IL-4,IFN-γ,TGF-β mRNA的表达水平.结果: NOD鼠口服胰岛素组30周龄和52周龄时发病率为55.6%和70.4%,分别比PBS对照组(85.7%和96.4%)低(P＜0.05).胰岛素组胰岛炎积分比对照组低,但差异无统计学意义(P＞0.05).胰岛素组胰岛Fas抗原表达和β细胞凋亡率均比PBS对照组低(均P＜0.05).胰岛素组胰岛内I-Aβg7,IFN-γ,IL-1β,Fas mRNA和PP淋巴结IFN-γ mRNA表达均较PBS对照组低(均P＜0.05),而IL-4,TGF-β mRNA表达较对照组高(均P＜0.05);胰岛素组血清IL-4比PBS组高,IFN-γ比PBS组低(均P＜0.05).结论:口服胰岛素能诱导NOD鼠的免疫耐受而预防糖尿病的发生,但不能阻断胰岛炎的进展.口服胰岛素能诱导调节性T细胞产生,使全身和胰岛局部T细胞由Th1向Th2转型,从而抑制Fas介导的β细胞凋亡而预防糖尿病.     

痹肿消汤对实验性关节炎大鼠血浆TNF-α及IL-1β的影响

目的：观察痹肿消汤（bizhongxiao decotion, BZXD）对实验性关节炎大鼠血浆肿瘤坏死因子α（tumornecrosis factorα,TNF-α）和白细胞介素-1β（interleukin-1β,IL-1β）的影响，探讨痹肿消汤治疗类风湿性关节炎(rheumatoid arthritis，RA)的作用机制。方法：75只SD大鼠随机分为4组，皮下注射Ⅱ型胶原诱导实验性关节炎模型，采用放射免疫法检测各组大鼠不同时间血浆TNF-α和IL-1β水平。结果：造模大鼠88%出现关节炎症状；造模25d后，模型组、痹肿消汤组及甲氨喋呤组大鼠TNF-α和IL-1β水平明显高于正常组（P<0.05）；且模型组TNF-α和IL-1β水平明显高于痹肿消汤组及甲氨喋呤组（P<0.01）；随着时间延长，模型组TNF-α和IL-1β水平逐渐升高，痹肿消汤组及甲氨喋呤组则逐渐降低；而痹肿消汤组TNF-α和IL-1β水平低于甲氨喋呤组（P<0.05）。结论：TNF-α和IL-1β在RA滑膜组织炎症形成和发展中发挥着重要作用；痹肿消汤与甲氨喋呤均能下调血浆TNF-α和IL-1β水平，但痹肿消汤的作用优于甲氨喋呤。     

夏枯草口服液应用于乳腺纤维腺瘤手术后的临床研究

[目的]探讨乳腺纤维腺瘤手术后使用夏枯草口服液与其术后切口感染的关系.[方法]采用前瞻性随机对照的方法收集202例乳腺纤维腺瘤手术后患者,按随机数表法分为治疗组(101例)和对照组(101例),对照组的患者采用常规治疗,治疗组患者在术后第1天在常规治疗的基础上给予夏枯草口服液治疗,治疗时间为4周.对两组患者的血清反应蛋...     

头针对急性脑缺血再灌注大鼠炎症反应的影响

目的:探讨头针治疗脑缺血的作用机制。方法:将70只健康SD雌性女鼠随机分为假手术组、模型组和头针组,模型组和头针组再根据缺血再灌注时间的不同(24h、48h、72h),各随机分为3个亚组。采用大脑中动脉线栓法制备大脑中动脉闭塞(middle cerebral artery occlusion.MCAO)再灌注模型,应用神经功能缺损评分(neurological seventy score,NSS)、HE染色及酶联免疫吸附反应观察急性脑缺血再灌注各时间点头针对模型大鼠神经功能缺损,缺血脑组织的炎性浸润,血浆及缺血脑组织肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-1β(interleu- kin-1β,IL-1β)和IL-10含量的影响。结果:头针组与模型组各时相的NSS比较,差异均有统计学意义(P<0.01),以脑缺血再灌注72h时较明显。头针组各时相白细胞浸润较模型组明显减少(P<0.01),以脑缺血再灌注72h最为明显。头针组与模型组比较,各时相血浆和脑组织TNF-α、IL-1β的拿量均减少,造模后72h,两组比较差异有统计学意义(P<0.01);IL-10的分量则增高,造模后48和72h,两组比较差异有统计学意义(P<0.05.P<0.01)。结论:头针有利于大鼠脑神经功能的恢复,可减轻急性恼缺血再灌注后白细胞的浸润,并在一定范围内降低TNF-α和IL-1β表达,增强IL-10表达,从而减缓由其个导的炎症免疫反应,减轻脑缺血再灌注损伤。     

蜂毒对大鼠佐剂性关节炎的影响

目的：复制大鼠佐剂性关节炎动物模型,并探讨蜂毒注射液在佐剂性关节炎中的疗效以及作用机制。方法：32只雄性SD大鼠,6只为正常对照组,26只大鼠用于佐剂性关节炎的模型制作,模型复制成功20只。将20只佐剂性关节炎大鼠随机分为3组,模型对照组6只、生理盐水治疗组6只、蜂毒治疗组8只。其中,模型对照组6只大鼠在治疗前进行处死,作为治疗前的水平。蜂毒治疗组大鼠每日皮下注射蜂毒注射液,连续14d。生理盐水治疗组大鼠注射相同体积的生理盐水。治疗前后记录关节周径、关节总体评分,治疗前后行X线检查,治疗结束时取血行TNF—α,IL-1β的检测及滑膜组织普通光镜检查。结果：与生理盐水治疗组的大鼠相比,蜂毒治疗组大鼠关节肿胀明显减轻,关节周径减少以及关节总体评分下降（P〈0.05）。生理盐水治疗组大鼠X线检查骨质破坏,滑膜炎性细胞浸润比蜂毒治疗组大鼠明显。蜂毒治疗组大鼠血清中TNF—α,IL—1β的浓度比生理盐水治疗组的低（P〈0.05;P〈0．01）。结论：蜂毒对大鼠佐剂性关节炎有效,能减少滑膜中炎性细胞浸润,减少血管翳生成,降低血清中TNF—α及IL—1β水平,减轻骨质破坏。